Dishman Carbogen Amcis Ltd.
Snapshot View

View in App

Prices View details >>

129.75 +5.15 ▲4.1%

29 March 2023, 04:01:00 PM
Volume: 48,440

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.dishmangroup.com
Market Cap 2,034.26 Cr.
Enterprise Value(EV) 3,421.69 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.24 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 32.17 Trailing Twelve Months Ending 2022-12
Book Value / Share 357.24 Trailing Twelve Months Ending 2022-12
Price to Book Value 0.36 Calculated using Price: 129.75
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 15.68 Cr. 156,783,095 Shares
FaceValue 2
Company Profile
The company is a fully integrated CRAMS player working with global pharmaceutical innovators. It has a global presence with development and manufacturing facilities across Europe, India, and China. It provides end-to-end, integrated, high-value, niche CRAMS offering, right from process research & development to late-stage clinical and commercial manufacturing facilities along with the supply of Active Pharmaceutical Ingredients (API) to innovator pharmaceutical companies.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.13%
1 Week
-6.05%
1 Month
+10.61%
3 Month
+44.41%
6 Month
+36.44%
1 Year
-29.54%
2 Year
+18.71%
5 Year
-59.53%
10 Year

Ratios View Details >>

6 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 3,654.02 6.05 4.01 2.86 -2.89 0.32
Return on Capital Employed (%) 4.60 4.67 5.79 3.93 -0.26 0.76
Return on Assets (%) 2.21 2.25 2.90 2.04 -2.00 0.21

Balance Sheet View Details >>

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 4,814 5,107 5,379 5,715 5,699 5,549 5,554
Non Curr. Liab. 767 884 743 909 1,367 1,665 1,644
Curr. Liab. 994 1,178 1,198 1,569 1,290 1,420 1,620
Minority Int.
Equity & Liab. 6,574 7,169 7,321 8,193 8,356 8,634 8,818
Non Curr. Assets 5,241 5,623 5,767 6,414 6,652 6,795 6,906
Curr. Assets 1,333 1,546 1,554 1,779 1,704 1,839 1,912
Misc. Exp. not W/O
Total Assets 6,574 7,169 7,321 8,193 8,356 8,634 8,818

Profit Loss View Details >>

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,714 1,695 2,059 2,044 1,912 2,141 2,363
Other Income 26 53 54 44 39 49 25
Total Income 1,740 1,748 2,112 2,088 1,951 2,190 2,389
Total Expenditure -1,260 -1,257 -1,507 -1,546 -1,638 -1,815 -2,061
PBIDT 479 491 606 542 313 375 328
Interest -49 -49 -57 -62 -48 -57 -77
Depreciation -214 -211 -240 -283 -308 -308 -289
Taxation -71 -76 -98 -39 -100 22 49
Exceptional Items -22 -15 -15
PAT 145 155 210 159 -165 18 -4
Minority Interest
Share Associate
Other Related Items 15
Consolidated Net Profit 161 155 210 159 -165 18 -4
Adjusted EPS 10 13 10 -11 1 0

Cash Flow View Details >>

Particulars 6 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 303 226 282 585 513 355
Cash Fr. Inv. -142 -297 -169 -442 -380 -619
Cash Fr. Finan. -137 78 -102 -98 -11 130
Net Change 23 7 11 46 122 -133
Cash & Cash Eqvt 59 66 76 122 244 110

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 61.93 59.32 59.32 59.32 59.32 59.32 59.32 59.32 59.32
Public 38.07 40.68 40.68 40.68 40.68 40.68 40.68 40.68 40.68
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 30 Mar 2023
Closure of Trading Window
We would like to inform that as per Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time the Trading Window for dealing in securities/ shares of the Company shall remain closed with effect from 1st April 2023 for all the Directors Designated Persons and their immediate relative(s). The Trading Window will be opened 48 hours after the announcement of the Audited Financial Results of the Company for the quarter and year ended 31st March 2023.
Fri, 10 Mar 2023
Board Meeting Outcome for BOARD APPROVES ISSUE OF SENIOR RATED LISTED SECURED REDEEMABLE NON-CONVERTIBLE DEBENTURES AGGREGATING UP TO RS. 100 CRORES
We would like to inform you that the Board of Directors of the Company has at its meeting held today i.e. Friday March 10 2023 which was commenced at 03:00 p.m. and concluded at 04:45 p.m. approved issuance of up to 10 000 (Ten thousand) senior rated listed secured redeemable non-convertible debentures of face value of Rs. 1 00 000/- (Rupees One Lac only) each aggregating up to Rs. 100 00 00 000/- (Rupees One Hundred Crores) on a private placement basis (the Issue or Debentures or NCDs).The Disclosures with respect to the Debentures pursuant to SEBI circular bearing reference number: CIR/CFD/CMD/4/2015 dated September 9 2015 read with Regulation 30 of the SEBI LODR Regulations is attached as Annexure - I with the file AND detailed disclosure also mentioned in the file.
Tue, 07 Mar 2023
Board Meeting Intimation for Consideration And Approval Of The Proposal Of Fund Raising By Way Of Issuance Of Non-Convertible Debentures By Way Of Private Placement Subject To Such Regulatory Or Statutory Approvals As May Be Required
Dishman Carbogen Amcis Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2023 inter alia to consider and approve the proposal of fund raising by way of issuance of Non-Convertible Debentures by way of private placement subject to such regulatory or statutory approvals as may be required

Technical Scans View Details >>

Wed, 29 Mar 2023
Close Crossing Last Month High Close Crossing Last Month High
Closing Above Previous High Closing Above Previous High
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 237,702.12 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. 76,011.65 4,564.50 +0.8%
Divi's Laboratories Ltd. 74,827.63 2,818.70 +0.5%
Cipla Ltd. 71,662.87 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. 62,756.97 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. 52,113.83 1,554.65 +0.7%
Zydus Lifesciences Ltd. 49,628.37 490.30 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 56.44 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.86 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 31.22 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 27.16 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 82.20 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.32 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 24.08 490.30 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.37 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-12 5.66 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-12 3.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.90 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 7.53 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.77 490.30 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 0.04 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 490.30 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 13.10 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 490.30 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 490.30 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 990.70 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,564.50 +0.8%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,818.70 +0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 887.85 -0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,371.75 +1.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,554.65 +0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 490.30 +1.2%

FAQ's On Dishman Carbogen Amcis Ltd.

What is Dishman Carbogen Amc share price?
Can I buy Dishman Carbogen Amc shares now?
What is the Market Cap of Dishman Carbogen Amc?
What are the key metrics to analyse Dishman Carbogen Amc?
What is the 52 Week High and Low of Dishman Carbogen Amc?
What is the trend of Dishman Carbogen Amc share price?